On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
FridayMar 20, 2020 12:29 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc.’s (PBIO) UST Demonstration Laboratory Showcases Groundbreaking Technology

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform-technology solutions to the worldwide life sciences and other industries, recently announced the opening of its new Ultra Shear Technology(TM) (“UST”) Demonstration Laboratory (http://ibn.fm/veoMI). An article discussing the company reads, “The main goal of the UST Demo Lab is to showcase the ability of the company’s revolutionary UST Platform to process cannabidiol (‘CBD’) oil into water-soluble nanoemulsions of superior quality. CBD nanoemulsions are expected to be more stable and offer higher bioavailability than the standard macro and microemulsions used in the vast…

Continue Reading

ThursdayMar 12, 2020 9:42 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Receives Order for Game-Changing UST System from Can B Corp. (CANBD)

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced its receipt of a purchase order from a new customer, Can B Corp. (OTCQB: CANBD). According to the update, the order is for one of PBIO’s proprietary BaroShear K45 Ultra Shear Technology(TM) ("UST")-based systems for processing CBD oil into stable, effectively water-soluble, highly absorbable nanoemulsions of oil in water. The nanoemulsions are expected to exhibit bioavailability levels that far exceed the absorption efficiency of today's macro or microemulsions of…

Continue Reading

TuesdayMar 10, 2020 12:07 pm

Pressure BioSciences Inc. (PBIO) Opens UST Demonstration Lab, Ushering in New Era in CBD Water-Soluble Nanoemulsion Preparation

The new facility is designed to demonstrate the company’s innovative Ultra Shear Technology’s ability to create CBD oil nanoemulsions of superior stability, aesthetics, and bioavailability Company has received orders for nine UST-based BaroShear K45 proprietary systems, with three more anticipated shortly, for an overall value of $2.4 million Global nanoemulsion market estimated to rise to $14.91 billion by the end of 2025 Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, and other industries, recently announced the opening of their new Ultra…

Continue Reading

ThursdayFeb 27, 2020 11:07 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Announces Official Opening of its Ultra Shear Technology(TM) Demonstration Laboratory

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics and other industries, today announced the official opening of its new Ultra Shear Technology(TM) ("UST") Demonstration Laboratory. According to the update, the major purpose of the UST Demo Lab, located in the company's South Easton, Massachusetts facility, is to showcase the ability of the company's revolutionary UST Platform to process CBD oil into true, high quality, water-soluble nanoemulsions. A second purpose is to invite potential purchasers of Pressure BioSciences’ UST-based BaroShear Systems (initial release…

Continue Reading

FridayFeb 07, 2020 12:28 pm

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Featured in Updated Research Report by Zacks SCR

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced that Zacks Small Cap Research ("Zacks SCR") has released an updated research report in its on-going coverage on the Company. Copies of the new Zacks SCR report are available via the following link: http://ibn.fm/n3zPF To view the full press release, visit http://ibn.fm/eTnSG About Pressure BioSciences Inc. Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. The company’s products are…

Continue Reading

ThursdayJan 30, 2020 11:45 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Announces Plans to Release Benchtop UST-Based BaroShear Instrument in Q3 2020

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced its plans to release a benchtop, R&D scale, Ultra Shear Technology(TM) (“UST”)-based BaroShear instrument to the market in the third quarter of 2020. Per the update, Pressure BioSciences believes this new instrument will address a significant un-met need in product formulation and development laboratories throughout cannabis, cosmetics, nutraceuticals, pharmaceuticals, and other large and diverse markets for processing CBD and other oils into stable, effectively water-soluble, highly absorbable nanoemulsions of…

Continue Reading

FridayJan 24, 2020 11:06 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Receives Significant New Order, Expects Several More for Revolutionary Nanoemulsification System for Water-Soluble CBD Oil

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced its receipt of a purchase order from a new customer for six proprietary Ultra Shear Technology(TM) (“UST”)-based nanoemulsification systems for processing CBD oil into stable, effectively water-soluble, highly absorbable nanoemulsions of oil in water. According to the update, such nanoemulsions are expected to exhibit bioavailability levels that far exceed those of today's macro or microemulsions of CBD oil. “In addition to the new order for six BaroShear K45 systems,…

Continue Reading

FridayJan 17, 2020 12:16 pm

QualityStocksNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Innovative UST Platform Featured in Leading North American Cannabis Publication

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced that its new and innovative Ultra Shear Technology(TM) (“UST”) platform was featured in Cannabis Brightline, one of North America's leading cannabis publications. Per the update, Focus Media Group (“FMG”) of Halifax, NS, Canada wrote and published the article. “This article highlights a critical issue facing the cannabis market today: the low bioavailability of CBD from CBD-infused products,” Jason Ellis, president of Vegas CBD Factory and recognized expert in the…

Continue Reading

ThursdayJan 16, 2020 3:15 pm

QualityStocksNewsBreaks – Zacks Small Cap Research Issues Update, Maintains Price Target on Pressure BioSciences Inc. (PBIO)

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform-technology solutions to the life sciences and other industries, was recently covered in a research report by Zacks Small Cap Research, a division of Zacks Investment Research. Among other highlights, Zacks maintained its $4.44 share price target on shares of PBIO. An article discussing the company reads, “The Zacks report (http://ibn.fm/z1W3H) points to demand that ‘is expected to accelerate starting in 2020,’ which nonetheless follows many years of consistent yearly revenue increases by PBIO. The company itself is standing by its stated…

Continue Reading

ThursdayJan 09, 2020 12:53 pm

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Announces Second Straight Year of Strong Publication Numbers of Scientific Papers Citing Advantages of its PCT Platform

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the life sciences and other industries, today announced that in 2019 - for the second straight year - over 20 scientific papers highlighting the advantages of PBI's patented pressure cycling technology ("PCT") platform were published worldwide. The publications, authored by independent scientists from academia, government, and industry, highlighted the powerful and enabling benefits of the PCT Platform in such critical areas as cancer research, food safety, and proteomics. “PCT-related scientific papers published in 2019 highlighted new and/or improved…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered